Skip to main content
Skip to footer
Services
Project Management
Study Start-Up & Regulatory
Patient Journey, Recruitment & Retention
Clinical Trial Monitoring
Data Science
Biostatistics
Medical Services & Monitoring
Pharmacovigilance
Quality Assurance & Compliance
Decentralized Clinical Trials
Therapeutic Expertise
Oncology & Hematology
Rare Diseases
Neurosciences
Infectious Diseases & Vaccines
Metabolic & Endocrinology
Cardiovascular
Advanced Therapy Medicinal Products
Other Areas of Expertise
Danah
Insights
About Us
Careers
Services
Project Management
Study Start-Up & Regulatory
Patient Journey, Recruitment & Retention
Clinical Trial Monitoring
Data Science
Biostatistics
Medical Services & Monitoring
Pharmacovigilance
Quality Assurance & Compliance
Decentralized Clinical Trials
Therapeutic Expertise
Oncology & Hematology
Rare Diseases
Neurosciences
Infectious Diseases & Vaccines
Metabolic & Endocrinology
Cardiovascular
Advanced Therapy Medicinal Products
Other Areas of Expertise
Danah
Insights
About Us
Careers
Get in touch
Archive:
RareDisease
March 20th, 2025
Raising awareness for a rare disease
February 6th, 2019
Pivotal starts enrolment in a phase II clinical trial in patients with Von Hippel-Lindau (VHL) disease developing renal cell cancer
Connect with us
Category
Submit an RFP
Book a meeting
Request a Danah Demo
Submit an inquiry
Yes, I have read, understood and accept the
consent form
for processing my personal data.
Send us a message
